February 01, 2015 3:58 AM ET


Company Overview of VaxGen Inc.

Company Overview

As of July 28, 2010, VaxGen Inc. was acquired by diaDexus, Inc., in a reverse merger transaction. VaxGen, Inc. does not have significant operations. The company seeks to enter into a strategic transaction or series of strategic transactions. Previously, it engaged in the development of vaccines that immunize against infectious disease. The company was founded in 1995 and is based in South San Francisco, California.

379 Oyster Point Boulevard

Suite 10

South San Francisco, CA 94080

United States

Founded in 1995

3 Employees





Key Executives for VaxGen Inc.

VaxGen Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Intarcia Therapeutics, Inc. United States
AorTx, Inc. United States
Fibercell Systems Inc. United States
Onyx Pharmaceuticals, Inc. United States
VICAM LP United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VaxGen Inc., please visit www.vaxgen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.